Merck Struggles to Hold Gains Amid Cautious Technical Indicators

Merck's shares are struggling to stay above recent lows as the broader technical picture remains cautious. Despite closing at $144.91 USD on the NYSE, up 0.78% from the previous close, the stock is still below its short-term trend line and well under the upper half of its recent trading range.

The chart shows that Merck is sitting in a sideways trend, with the SMA20 slope up 1.59% over 5 days indicating that the recent bounce has not fully disappeared. However, the price being below the 20-day average matters, as it suggests that the stock has not yet convinced the market that the latest recovery is strong enough to retake control of the short-term tape.

The RSI at 52.4 and Stochastic %K at 24.7 are neutral, indicating neither overbought nor oversold conditions, but the negative MACD suggests momentum is still lagging behind. The stock's volume is low, with a ratio of 0.7x normal, and OBV is down, supporting the view that the rebound lacks participation.

The nearby floor is $143.79, while the immediate ceiling is $156.45. A clean move back above the Bollinger middle band at $149.10 would be significant, as it would indicate a change in market sentiment.